Finoriq research workspace
Biofrontera Inc. (BFRI) Institutional Holdings & 13F Ownership
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of. Review BFRI institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
- Company
- Biofrontera Inc. (BFRI)
- Ticker
- BFRI
- Market Cap
- $13.6M
- Latest Price
- $1.065
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.